More patients will be taking aspirin for primary prevention of coronary heart disease (CHD)

February 2002

More patients will be taking aspirin for primary prevention of coronary heart disease (CHD)...based on the latest recommendations from the U.S. Preventive Services Task Force.

Using aspirin for SECONDARY prevention is well-accepted...aspirin for PRIMARY prevention has been more controversial.

Now there's evidence that aspirin reduces the risk of cardiovascular events by 28%...but it also increases the risk of GI bleeding and hemorrhagic stroke.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote